Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania

Jeffrey I Joseph, D.O. has practiced anesthesiology and medical device innovation at the Department of Anesthesiology, Sidney Kimmel Medical College of Thomas Jefferson University for 34 years. Dr. Joseph is a Professor of Anesthesiology, Vice-Chairman, Director of Research, and Founder/Director of the Jefferson Artificial Pancreas Center. His research has focused on the development and clinical application of devices for glucose monitoring, insulin delivery, artificial pancreas and vital sign monitoring in hospitalized and ambulatory patients. Dr. Joseph co-founded Animas Corporation, Inc. in 1994 to commercialize an implantable optical glucose sensor and insulin delivery system. Animas had a successful Initial Public Offering (Nasdaq: PUMP) in 2004 and was acquired by Johnson and Johnson in 2006.

Dr. Joseph co-founded Capillary Biomedical, Inc. in 2014 to commercialize CSII catheters with rapid/consistent PK-PD, leading to an optimized closed-loop artificial pancreas system. He is the Chairman of Capillary Biomedical’s Scientific and Clinical Advisory Boards. Dr. Joseph also co-founded RTM Vital Signs, LLC in 2014 to commercialize an implantable vital sign monitoring system with real-time diagnostic/therapeutic algorithms and data transmitted via cell phone to a central monitoring station for computer and clinical interpretation. He is also the Chairman of RTM Vital Sign’s Scientific and Clinical Advisory Boards. The Jefferson Artificial Pancreas Center is focused on medical device innovation, in-vitro testing, large animal testing, and human clinical testing with recent support from the Juvenile Diabetes Foundation, the National Institutes of Health, Capillary Biomedical, Inc. and RTM Vital Signs, LLC.